Snowball logo
logo
EKTA_logo

Elekta AB (publ)

SEK 53.70+SEK 1.40  (2.68%)
Estimate
EPS
-1.4
Beta
0.968
Growth
Revenue, YoY
-7.64%
Net income, YoY
-124.35%
FCF, YoY
7.53%
Forecast
P/E (FWD)
13.3
EPS (FWD)
4.051
Dividends
Dividend yield
4.47%
Annual payout
SEK 2.40
Next ex. div date
September 4, 26
Div.growth, 5y
5.92%
Div.rating
About the company
Ticker
EKTA-B
ISIN
SE0000163628
Country
Sweden
Sector (GICS)
Healthcare
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Elekta Care, a personalized services for radiotherapy suites. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Elekta Geneva, an applicator for cervical cancer patients; and Elekta Xoft Axxent electronic brachytherapy systems. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning; Elekta Care Community, a self-help center; and Elekta Partner Community, an online self-service portal. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Frequently asked questions

What sector does Elekta AB (publ) (EKTA-B) operate in?

Elekta AB (publ) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Elekta AB (publ) (EKTA-B) current stock price?

As of the latest data, Elekta AB (publ) stock price is SEK 53.70, with a previous close of SEK 52.30. Elekta AB (publ) gained SEK 1.40 in the last trading session, representing a 2.68% increase.

What is Elekta AB (publ) (EKTA-B) current market capitalization?

Elekta AB (publ) market cap is approximately 19.71 billion.

What is Elekta AB (publ) (EKTA-B) Earnings Per Share (EPS)?

The trailing EPS is -SEK 1.40, and the forward EPS is SEK 4.05.

What is Elekta AB (publ) (EKTA-B) EBITDA?

Elekta AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 69.00 million.

Does Elekta AB (publ) (EKTA-B) pay dividends?

Yes. Elekta AB (publ) pays semiannual dividends with an annualized yield of 4.47% and an estimated annual payout of SEK 2.40 per share.

When is the next ex-dividend date for Elekta AB (publ) (EKTA-B)?

The next ex-dividend date is scheduled for September 04, 2026.

How did Elekta AB (publ) (EKTA-B) perform in its most recent earnings report?

In the last report (April 30, 2026), Elekta AB (publ) posted an EPS surprise of -57.78% and a revenue surprise of -71.93%.

When is Elekta AB (publ) (EKTA-B) next earnings report?

Elekta AB (publ) is expected to release its next earnings report on July 31, 2026.

What is Elekta AB (publ) (EKTA-B) beta (volatility) score?

Elekta AB (publ) has a beta of 0.968, meaning its volatility is roughly in line with the market.